Colon Cancer

April 7, 2015September 12, 2016

New Home Test Kit Launched for Crohn’s and Ulcerative Colitis

Germany-based Bühlmann Laboratories has launched IBDoc, described as “the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home.” The announcement marks the continuing advancement toward personalized medicine. ... Read more

March 26, 2015September 28, 2016

Mongersen Shows Promise for Crohn’s Disease

Colon Cancer, Crohn's Disease, News

A new treatment for Crohn’s disease is showing promise in clinical trials. Giuliani, an Italian pharmaceutical company, conducted a phase 2 clinical study of more than 150 adult patients with Crohn’s disease ... Read more

January 16, 2015

Crohn’s & Colitis Foundation Partners With ResearchMatch To Improve Quality of Life For IBD Patients

Colon Cancer, News

ResearchMatch (RM) and the Crohn’s & Colitis Foundation of America (CCFA) have joined forces to establish a partnership to improve the quality of life of the adults and children affected with Crohn’s ... Read more

December 8, 2014December 8, 2014

SetPoint Starts Trial on Bioelectronic Therapy for Crohn’s Disease

Colon Cancer, News

SetPoint Medical, a biotech company developing therapies for inflammatory bowel diseases (IBD), announced that it is now evaluating safety and efficacy for its novel treatment for Crohn’s disease. The announcement was made by ... Read more

December 4, 2014December 4, 2014

Crohn’s & Colitis Foundation Co-Funded Study Sheds Light On Immune System, Inflammation

Colon Cancer, Crohn's Disease, News

A new study on a potential regulation mechanism of autoimmunity and anti-tumor immunity entitled “CEACAM1 regulates TIM-3-mediated tolerance and exhaustion” was published in Nature by Yu-Hwa Huang, part of Dr. Richard ... Read more

November 13, 2014November 13, 2014

GI Cancer Becomes Leading Cause of Cancer Death in Europe

Colon Cancer, News

Gastrointestinal (GI) cancer is the new leading cause death by cancer in Europe, according to a major pan-European survey commissioned by United European Gastroenterology (UEG), which revealed several trend alterations regarding both GI and liver diseases as ... Read more

October 29, 2014October 29, 2014

Lipids Present in Modern Western Diet May Trigger Inflammation, Colon Cancer

Colon Cancer, IBD News, News

A new study entitled “Sphingosine-1-phosphatelyase down regulation promotes coloncarcinogenesis through STAT3-activatedmicroRNAs” discovered that a class of lipids present in our diet — sphingolipids — can promote or protect colon cancer ... Read more

October 13, 2014September 28, 2016

New Oral Biologic Medication Reduces Precancerous Polyp Formation In The Colon

Colon Cancer, News

Animal study results reported by researchers at the University at Buffalo School of Medicine and Biomedical Sciences and covered in a UB News release show that a new oral biologic ... Read more

October 9, 2014October 9, 2014

Second Genome and Mayo Clinic Partner for Microbiome Treatment Research

Colon Cancer, IBD News, News

Research into some of the world’s most prevalent and deadly gastrointestinal disease is set to take a new turn in researching and developing a new class of therapeutics. A new ... Read more

August 21, 2014August 21, 2014

Vitamin D Found to Reduce Colon Cancer Risk in Mice with IBD

Colon Cancer, IBD News, News

Vitamin D, a powerhouse vitamin that is associated with numerous health benefits, is now associated with lowering the risk for colon cancer. The laboratory of Dr. Lillian Maggio-Price in the Department ... Read more